✦ LIBER ✦

Efficacy and Safety of Single-Agent Axitinib (AG-013736; AG) in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Phase II Trial

✍ Scribed by J.H. Schiller; J. von Pawel; T. Larson; S.I. Ou; S.A. Limentani; A.B. Sandler; E.E. Vokes; S. Kim; K.F. Liau; P.W. Bycott

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6551 POSTER Efficacy and safety of singl

✍ von Pawel, J.; Larson, T.; Ou, S.I.; Limentani, S.A.; Sandler, A.B.; Vokes, E.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II trial of MTA (AlimtaTM) and cis

✍ Shepherd, F.A; Arnold, A; Neville, A; Dancey, J; Rusthoven, J; Fisher, B; Eisenh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A Phase I Trial of Sunitinib and Rapamyc

✍ Waqar, Saiama N.; Gopalan, Priya K.; Williams, Kristina; Devarakonda, Siddhartha 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 428 KB

A phase I trial of gefitinib and nimotuz

✍ Kim, Se Hyun; Shim, Hyo Sup; Cho, Jaeho; Jeong, Jae Heon; Kim, Sun Mi; Hong, Yun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 275 KB

A phase I/II trial of carboplatin and na

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB